Literature DB >> 23224098

How many sputum culture results do we need to monitor multidrug-resistant-tuberculosis (MDR-TB) patients during treatment?

Saskia Janssen1, Xavier Padanilam, Rianna Louw, Russel Mahanyele, Gerrit Coetzee, Thomas Hänscheid, Tjalling Leenstra, Martin P Grobusch.   

Abstract

Discharge of a hospital patient after a single negative sputum culture may save money when treating multidrug-resistant tuberculosis. However, after initial sputum conversion in 336 South Africans, 11.6% and 5.4% reconverted after 1 and 2 months, respectively. These findings endorse the WHO definitions of 2 negative cultures taken ≥ 30 days apart after sputum culture conversion.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23224098      PMCID： PMC3553933          DOI： 10.1128/JCM.02837-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment.

Authors:  E V Kurbatova; V M Gammino; J Bayona; M Becerra; M Danilovitz; D Falzon; I Gelmanova; S Keshavjee; V Leimane; C D Mitnick; M I D Quelapio; V Riekstina; A Taylor; P Viiklepp; M Zignol; J P Cegielski
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

2.  Household screening and multidrug-resistant tuberculosis.

Authors:  Helen Cox; Gilles van Cutsem
Journal:  Lancet       Date:  2010-12-08       Impact factor: 79.321

3.  Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Authors:  K F Laserson; L E Thorpe; V Leimane; K Weyer; C D Mitnick; V Riekstina; E Zarovska; M L Rich; H S F Fraser; E Alarcón; J P Cegielski; M Grzemska; R Gupta; M Espinal
Journal:  Int J Tuberc Lung Dis       Date:  2005-06       Impact factor: 2.373

Review 4.  Drug-resistant and extensively drug-resistant tuberculosis in southern Africa.

Authors:  Martin Peter Grobusch
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

5.  Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.

Authors:  Sean P Fitzwater; Luz Caviedes; Robert H Gilman; Jorge Coronel; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Krishna Reddy; Jon S Friedland; David A J Moore
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

6.  WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.

Authors:  D Falzon; E Jaramillo; H J Schünemann; M Arentz; M Bauer; J Bayona; L Blanc; J A Caminero; C L Daley; C Duncombe; C Fitzpatrick; A Gebhard; H Getahun; M Henkens; T H Holtz; J Keravec; S Keshavjee; A J Khan; R Kulier; V Leimane; C Lienhardt; C Lu; A Mariandyshev; G B Migliori; F Mirzayev; C D Mitnick; P Nunn; G Nwagboniwe; O Oxlade; D Palmero; P Pavlinac; M I Quelapio; M C Raviglione; M L Rich; S Royce; S Rüsch-Gerdes; A Salakaia; R Sarin; D Sculier; F Varaine; M Vitoria; J L Walson; F Wares; K Weyer; R A White; M Zignol
Journal:  Eur Respir J       Date:  2011-08-04       Impact factor: 16.671

7.  Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.

Authors:  Mercedes C Becerra; Sasha C Appleton; Molly F Franke; Katiuska Chalco; Fernando Arteaga; Jaime Bayona; Megan Murray; Sidney S Atwood; Carole D Mitnick
Journal:  Lancet       Date:  2010-12-08       Impact factor: 79.321

8.  Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Authors:  Timothy H Holtz; Maya Sternberg; Steve Kammerer; Kayla F Laserson; Vija Riekstina; Evija Zarovska; Vija Skripconoka; Charles D Wells; Vaira Leimane
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

9.  Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.

Authors:  V Sundaram; P I Fujiwara; C R Driver; S S Osahan; S S Munsiff
Journal:  Int J Tuberc Lung Dis       Date:  2002-03       Impact factor: 2.373

10.  Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?

Authors:  Jesús Fortún; Pilar Martín-Dávila; Auxiliadora Molina; Enrique Navas; José Manuel Hermida; Javier Cobo; Enrique Gómez-Mampaso; Santiago Moreno
Journal:  J Antimicrob Chemother       Date:  2007-04       Impact factor: 5.790
  10 in total
  2 in total

1.  Untreated Active Tuberculosis in Pregnancy with Intraocular Dissemination: A Case Report and Review of the Literature.

Authors:  Shadi Rezai; Stephen LoBue; Daniel Adams; Yewande Oladipo; Ramses Posso; Tiffany Mapp; Crystal Santiago; Manisha Jain; William D Marino; Cassandra E Henderson
Journal:  Case Rep Pulmonol       Date:  2015-11-26

Review 2.  Indications to Hospital Admission and Isolation of Children With Possible or Defined Tuberculosis: Systematic Review and Proposed Recommendations for Pediatric Patients Living in Developed Countries. [Corrected].

Authors:  Andrea Lo Vecchio; Marialuisa Bocchino; Laura Lancella; Clara Gabiano; Silvia Garazzino; Riccardo Scotto; Irene Raffaldi; Luca Rosario Assante; Alberto Villani; Susanna Esposito; Alfredo Guarino
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.